🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kai Han

China Pharmaceutical University

ORCID: 0000-0001-5370-4296

Also affiliated with Drug Discovery Laboratory (Norway)

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “1227 Oral inulin gel formulation modulates the gut microbiome and improves the safety and efficacy of immune checkpoint blockers”.

1227 Oral inulin gel formulation modulates the gut microbiome and improves the safety and efficacy of immune checkpoint blockers

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.1227

N/A

0DataRank · unranked

1 citations

Kai Han, Xuehui Huang, James J. Moon, Jin Xu

Novel strategies for modulating the gut microbiome for cancer therapy

Advanced Drug Delivery Reviews(2024)10.1016/j.addr.2024.115332

N/A

0DataRank · unranked

50 citations

Kai Han, Jin Xu, James J. Moon, Young Seok Cho

Inulin-gel-based oral immunotherapy remodels the small intestinal microbiome and suppresses food allergy

Nature Materials(2024)10.1038/s41563-024-01909-w

N/A

0DataRank · unranked

40 citations

Fang Xie, Olamide Animasahun, Minal Nenwani, Sho Kitamoto, Yeji Kim +25 more